REGULATED INFORMATION IN FRANCE Regulated information at a glance Facebook Twitter LinkedIn Annual financial reports VIEW ALL Half-year financial reports VIEW ALL Quaterly financial information VIEW ALL Report of the Chairman of the Board on corporate governance and internal control VIEW ALL Fees received by statutory auditors VIEW ALL Total number of voting rights and shares VIEW ALL Share repurchase programs VIEW ALL General meeting preparatory documents VIEW ALL Information published pursuant to article 223-21 of the AMF general regulation VIEW ALL Inside information VIEW ALL Press releases Download the PDF version November 18 2021 PRESS RELEASES Sanofi invests $180 million equity in Owkin’s artificial intelligence and federated learning to advance oncology pipeline Download the PDF version November 12 2021 PRESS RELEASES Sanofi announces results of CHMP re-examination of the New Active Substance status for avalglucosidase alfa, a potential new standard of care for the treatment of Pompe disease Download the PDF version November 09 2021 PRESS RELEASES Sanofi completes acquisition of Kadmon media-room Follow us Sanofi on Twitter Sanofi TV on YouTube Sanofi On LinkedIn Sanofi on Instagram Sanofi RSS feeds Contact Legal notice Privacy & Data Protection Cookies policy Corporate code of ethics Our publications Sitemap Our websites Accessibility: partial compliance © Sanofi 2004-2021 - All rights reserved